Tilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada

Tilray Medical Launches New Products and ‘CannaPoints’ Program to Support Patients Across Canada

TORONTO, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today announced that its medical cannabis division, Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support patients through their medical cannabis journey.

Read more here.